483 Fresenius Kabi USA Sep 2009

483 Fresenius Kabi USA Sep 2009

James Bridges FDA, Paul Mouris FDA$119.00 - Available Now

FDA investigators audited the Fresenius Kabi USA - Grand Island, NY, United States facility and issued inspectional observations (via FDA 483) on 17 Sep 2009.

Product details

  • Category: Human Drugs
  • Inspection end: 17 Sep 2009
  • Location: Grand Island, United States
  • FEI: 3001833549
Add To Cart